MAPT and Alzheimer disease: The advent of minimally invasive and in-vivo imaging of Aβ and tau in the human brain, as well as high-resolution structural imaging, enables the investigation of the link between well-documented AD neuropathology and neurodegeneration (Javaid, 2016, Mak, 2018, Villemagne and Okamura, 2016).